TrialBMC cancer2020

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.

Xinan Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.